Guillermo Alfonso Jaramillo, head of the Colombian Ministry of Health, announced the authorization of a new vaccination campaign against covid-19. During the campaign, 757,400 doses of the Moderna Bivalent immunological will be applied.
The strategy seeks to respond to the mutations that the virus has had in recent months and the number of confirmed cases of infections registered in the nation. Figures published by Statesman indicate that, until August 8 of this year, In Colombia, 6.3 million infections were confirmed.
“It is a vaccine that has new attributes because Covid-19 is changing. We have seen it now with the genomes studied by the National Institute of Health. The pathogen changes rapidly. “Covid is no longer the same as it was at the time of the pandemic,” Jaramillo said in an interview with the local media. Blue Radio. In recent days, the minister had said before the First Committee of the Senate that the vaccine against covid-19 was part of an international scientific experiment.
Mexico becomes the first country in Latin America to sell vaccines against COVID-19
The Federal Commission for the Protection against Health Risks (Cofepris) is the first agency on the continent to determine that the Pfizer and Moderna vaccines met the quality, safety and effectiveness requirements for their sale in pharmacies.
When will the new booster against covid-19 be available in Colombia?
Colombian authorities said that The vaccination campaign will begin on December 16. The process will follow the application parameters set in the Resolution 1862 published last November 15.
Who will be able to get the booster vaccine against covid-19 in Colombia?
The decree determines that pregnant people, residents over 60 years of age, health sector personnel and the population with comorbidities may request a booster six months after having received the last dose of the vaccine. It clarifies that, in the case of pregnant women, the Pfizer messenger RNA (mRNA) immunogen must be applied.
The inoculation plan in Colombia includes vaccines that contain messenger RNA and others with the virus. Under this consideration, the resolution warns that “if a person over 18 years of age was vaccinated with the Janssen active ingredient, they must receive a dose of mRNA vaccine at least six months after the initial one.”
The bivalent vaccine is available for the entire population over 18 years of age who have at least the first dose against covid-19. Health entities will give priority to high-risk groups and health personnel.
Minors between 12 and 17 years of age “will be able to access the additional dose of the mRNA vaccine six months after receiving the last dose,” according to the Ministry of Health document.
Covid-19 in the middle of the winter season
Last September, the World Health Organization (WHO) warned of “worrying trends” related to Covid-19 as winter approaches the northern hemisphere. The agency asked health authorities to reinforce vaccination campaigns and increase surveillance over the advance of the virus.
María Van Kerkhove, technical officer of the United Nations Health Agency for covid-19, estimated that “there are currently hundreds of thousands of people hospitalized with covid. This is worrying because we are going to have colder months in some countries. “People will spend more time together indoors, and viruses like Covid that are transmitted through the air will benefit,” she noted.
The WHO has repeatedly emphasized that Covid-19 is still a new disease about which there are many things to learn, even more so when new strains are in sight. The organization announced the formation of a new advisory committee for countries to optimize their response mechanisms to the virus in the long term with a focus on prevention against possible new pandemics.
2023-12-08 23:52:45
#Colombia #apply #bivalent #booster #dose #covid19
:strip_icc()/i.s3.glbimg.com/v1/AUTH_bc8228b6673f488aa253bbcb03c80ec5/internal_photos/bs/2023/h/t/dlAVo3TMAUxwmRVY7Dgg/agif23072622124180.jpg?resize=150%2C150&ssl=1)
